Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Naproxen × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 584 Paclitaxel 569 Cyclophosphamide 538 Docetaxel 480 Capecitabine 411 Letrozole 340 Carboplatin 322 Fulvestrant 312 Doxorubicin 279 Tamoxifen 242 pembrolizumab 225 Anastrozole 208 Epirubicin 204 exemestane 195 Radiotherapy 189 Bevacizumab 182 pertuzumab 180 Gemcitabine 173 Vinorelbine 161 Lapatinib 156 palbociclib 144 130-nm albumin-bound paclitaxel 139 Magnetic Resonance Spectroscopy 133 Albumin-Bound Paclitaxel 128 eribulin 123 Exercise 123 Fluorouracil 111 Taxes 107 Cisplatin 99 Everolimus 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01712009 2018-01-30

NOLAN

Amgen

Phase 2 Completed

600 enrolled 15 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡